Minimal change disease following vaccination for SARS-CoV-2

J Nephrol. 2021 Aug;34(4):1039-1040. doi: 10.1007/s40620-021-01091-1. Epub 2021 Jun 18.

Authors

Nicoletta Mancianti¹, Andrea Guarnieri², Sergio Tripodi³, Domenica Paola Salvo¹, Guido Garosi¹

Affiliations

¹ Department of Emergency-Urgency and Transplantation, Nephrology, Dialysis and Transplantation Unit, University Hospital of Siena, Siena, Italy.
² Department of Emergency-Urgency and Transplantation, Nephrology, Dialysis and Transplantation Unit, University Hospital of Siena, Siena, Italy. [email protected].
³ Department of Oncology, Pathology Unit, University Hospital of Siena, Siena, Italy.

No abstract available

Keywords: BioNTech/Pfizer vaccine; COVID-19; Glomerular disease; Minimal change disease; SARS-CoV-2 vaccine.

MeSH terms

COVID-19*
Health Personnel
Humans
Nephrosis, Lipoid*
SARS-CoV-2
Vaccination / adverse effects